Patents by Inventor Nikki Royle

Nikki Royle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC MOLECULES
    Publication number: 20230406954
    Abstract: The invention relates to binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
    Type: Application
    Filed: June 28, 2023
    Publication date: December 21, 2023
    Inventors: Brian McGuinness, Isabelle Osuch, Chris Rossant, Mike Romanos, Nikki Royle, Thomas Sandal, Lorraine Thompson, Michele Writer
  • Therapeutic molecules
    Patent number: 11746158
    Abstract: The invention relates to binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: September 5, 2023
    Assignee: Crescendo Biologics Limited
    Inventors: Brian McGuinness, Isabelle Osuch, Chris Rossant, Mike Romanos, Nikki Royle, Thomas Sandal, Lorraine Thompson, Michele Writer
  • Therapeutic molecules binding PSMA
    Patent number: 11401342
    Abstract: The invention relates to improved binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: August 2, 2022
    Assignee: CRESCENDO BIOLOGICS LIMITED
    Inventors: Nikki Royle, Steve Vance, Viviane Zelenay
  • Therapeutic Molecules
    Publication number: 20220112305
    Abstract: The invention relates to binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
    Type: Application
    Filed: October 22, 2021
    Publication date: April 14, 2022
    Inventors: Brian McGuinness, Isabelle Osuch, Chris Rossant, Mike Romanos, Nikki Royle, Thomas Sandal, Lorraine Thompson, Michele Writer
  • Therapeutic molecules
    Patent number: 11236174
    Abstract: The invention relates to binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: February 1, 2022
    Assignee: CRESCENDO BIOLOGICS LIMITED
    Inventors: Brian McGuinness, Isabelle Osuch, Chris Rossant, Mike Romanos, Nikki Royle, Thomas Sandal, Lorraine Thompson, Michele Writer
  • STABILIZED AQUEOUS ANTIBODY COMPOSITIONS
    Publication number: 20200138946
    Abstract: The present invention provides an aqueous solution comprising an antibody protein at a concentration of at least about 10 mg/mL and an oligomer of ethyleneimine, wherein the number of repeating units of ethyleneimine (n) in the oligomer is in the range of n=2-12.
    Type: Application
    Filed: November 27, 2019
    Publication date: May 7, 2020
    Inventors: Jan JEZEK, Guy CASY, Barry DERHAM, Nikki ROYLE
  • Therapeutic molecules binding PSMA
    Publication number: 20200131274
    Abstract: The invention relates to improved binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
    Type: Application
    Filed: July 9, 2018
    Publication date: April 30, 2020
    Inventors: Nikki Royle, Steve Vance, Vivien Zelenay
  • Stabilized aqueous antibody compositions
    Patent number: 10532098
    Abstract: The present invention provides an aqueous solution comprising an antibody protein at a concentration of at least about 10 mg/mL and an oligomer of ethyleneimine, wherein the number of repeating units of ethyleneimine (n) in the oligomer is in the range n=2-12.
    Type: Grant
    Filed: January 30, 2013
    Date of Patent: January 14, 2020
    Assignee: Arecor Limited
    Inventors: Jan Jezek, Guy Casy, Barry Kingston Derham, Nikki Royle
  • Stabilized Aqueous Antibody Compositions
    Publication number: 20150010548
    Abstract: The present invention provides an aqueous solution comprising an antibody protein at a concentration of at least about 10 mg/mL and an oligomer of ethyleneimine, wherein the number of repeating units of ethyleneimine (n) in the oligomer is in the range n=2-12.
    Type: Application
    Filed: January 30, 2013
    Publication date: January 8, 2015
    Applicant: Arecor Limited
    Inventors: Jan Jesek, Guy Casy, Barry Derham, Nikki Royle